At a glance
What Tilray Brands is
Tilray Brands is a Nasdaq- and Toronto-listed global consumer-products company spanning adult-use and medical cannabis, beverages, hemp foods and wellness. It is no longer accurately described as only a cannabis cultivator: by fiscal 2026, its beverage and cannabis divisions generated comparable scale.
Original Tilray and Privateer roots
The original Tilray business was launched in 2013 through Privateer Holdings by a founding team associated with Brendan Kennedy, Michael Blue and Christian Groh. It became an early federally licensed Canadian medical cannabis producer and was the first pure-play cannabis company to complete a U.S. Nasdaq IPO in 2018.
Aphria combination in 2021
Aphria acquired Tilray in a reverse-acquisition structure completed April 30, 2021, and the combined company retained the Tilray name and TLRY ticker. Aphria leader Irwin D. Simon became chief executive and chair. This transaction is the central break between the original Tilray startup and today's diversified public company.
Cannabis brand portfolio
Current cannabis brands include Good Supply, Broken Coast, Redecan, Solei, Tilray Medical, XMG and newer regional or medical labels. The portfolio varies by country because cultivation, prescription, packaging and adult-use rules differ. A brand sold in Canada is not automatically available or identically formulated elsewhere.
Medical cannabis footprint
Tilray's 2026 annual report says its medical products reach patients in more than 20 countries across five continents through subsidiaries and distributors. European operations include regulated cultivation, import and distribution. This is a corporate reach claim, not a guarantee that every product or prescription pathway is available in each country.
Beverage and wellness businesses
The company owns craft beer, spirits and beverage brands including SweetWater, Montauk, Breckenridge Brewery, Blue Point, Terrapin and Shock Top, plus Manitoba Harvest hemp foods. These products are generally distinct from regulated cannabis. Brand ownership does not mean an ordinary beer contains THC.
BrewDog acquisition in 2026
Tilray acquired key BrewDog global assets in March 2026 for £33 million, including brand intellectual property, UK brewing operations and eleven UK and Ireland brewpubs, then added other regional assets. Fiscal 2026 reporting included $51.1 million in BrewDog-related beverage revenue after the fourth-quarter closing.
Fiscal 2026 scale and risk
The 2026 Form 10-K reported beverage revenue of $254.0 million and identified leading Canadian cannabis revenue, while also describing impairment, integration, regulation and market risks. Revenue is not profit, adjusted measures are not GAAP net income and transaction projections should not be presented as realized results.
Research notes and claim limits. This profile prioritizes Tilray's newest SEC filing, investor materials and transaction disclosures. It distinguishes the 2013 company from the 2021 Aphria-led combination and separates cannabis from alcohol and hemp food. Investors should use live SEC filings for financial decisions; no share-price prediction or investment recommendation is made.